Argonaut's 3rd Annual PowerUsers Conference --- Integrating Islands of Automation.Business Editors/High-Tech Writers SAN CARLOS San Carlos (săn kär`lōs), residential city (1990 pop. 26,167), San Mateo co., W Calif.; inc. 1925. The chief manufactures are plastic products, hardware, and machine parts. , Calif., and INDIANAPOLIS--(BUSINESS WIRE)--Aug. 9, 2001 Argonaut Technologies, Inc. (Nasdaq:AGNT AGNT Association for Global New Thought AGNT Agent Table ) today announced that it hosted the 3rd Annual Argonaut PowerUsers Conference in Indianapolis, Indiana “Indianapolis” redirects here. For other uses, see Indianapolis (disambiguation). Indianapolis (IPA: [ˌɪndiəˈnæpəlɪs]) is the capital city of the U.S. . "Integrating Islands of Automation" was the theme for the conference. Leading researchers from the chemical and pharmaceutical industries presented over 15 technical papers describing the latest technologies for enhancing productivity in chemical research and development. The number of conference attendees doubled from last year, and included chemical engineers and scientists representing various companies including Pfizer, Eli Lilly Eli Lilly can refer to:
Ciba Specialty Chemicals is a chemical company based in and near Basel, Switzerland. It was formed as the non-pharmaceuticals elements of Novartis were spun out in 1997, following the merger in the , Dow AgroSciences Dow AgroSciences LLC is a wholly owned subsidiary of the Dow Chemical Company specializing in not only agricultural chemicals such as pesticides, but also seeds and biotechnology solutions. The company is based in Indianapolis, Indiana, in the United States. , Dow Chemical, Proctor & Gamble Pharmaceuticals, Bayer Corporation. With advances in instrumentation providing improved productivity, other activities, such as data collection from experiments, in-line data analysis and archival of related data, have emerged as limiting factors in chemical development. Dow AgroSciences' process scientists presented case studies that illustrated how they had utilized Argonaut products, such as the CLARK 4.0(TM) and Surveyor(TM), to achieve reliable, reproducible data to improve quality, increase productivity, and reduce errors. As evidenced by the other technical presentations at the conference, there are several approaches and instruments available from Argonaut that address both screening and rapid, reproducible scale up to streamline process chemistry. Those interested in abstracts of the presentations made at the PowerUsers Conference may contact Ben Schreiber at bschreiber@argotech.com or 317/573-3880 extension 30 for more information. Argonaut Technologies Argonaut Technologies, Inc. is a pioneer in the development of innovative products that speed and simplify how chemists discover and test new chemical entities. Our products enable chemists to increase their productivity, reduce their operating costs through automation and process simplification, achieve faster time-to-market for new products, and cost-effectively explore the increasing number of drug targets available for drug development. We provide solutions that are used in over 825 pharmaceutical, chemical and academic laboratories worldwide. Our instruments, software and consumables for parallel synthesis enable chemists to perform multiple experiments under a variety of conditions in a fraction of the time and cost of traditional methods. Forward Looking Statements Statements included in this press release that are not historical in nature may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Examples of such forward-looking statements include, without limitation, statements regarding the ability of Argonaut's products to enhance chemical development. Any such forward-looking statements involve risks and uncertainties and reflect Argonaut's judgment as of the date of this release. These and other risk factors are discussed in Argonaut's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2000 filed on April 2, 2001, as amended, in its quarterly report on Form 10-Q Form 10-Q See 10-Q. for the quarter ended March 31, 2001 filed on May 14, 2001, and its other filings with the Securities and Exchange Commission. Argonaut disclaims any intent or obligation to update these forward-looking statements. The Company claims the protection of the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion